Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The NIH-wide announcement about terminology changes during the agency transition is no longer displayed. The 403 error page remains otherwise unchanged.
    Difference
    1%
    Check dated 2026-11-08T09:26:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T11:12:59.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH website transition, links to updates and FAQs, and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T11:25:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:11:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision changes from v3.7.0 to v3.7.1; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-11T14:43:33.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden message instead of the usual content. This blocks access to the main trial details and navigation on that page.
    Difference
    18%
    Check dated 2026-09-20T20:09:54.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.